Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond J Muller

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 7, 2007
Extended-dosage-interval regimens of erythropoietic agents in chemotherapy-induced anemiaRaymond J Muller, David Baribeault
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 22, 2013
National survey on the effect of oncology drug shortages on cancer careAli McBride, Lisa M Holle, Colleen Westendorf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 3, 2007
Bevacizumab 5 mg/kg can be infused safely over 10 minutesDiane L Reidy, Ki Y Chung, John P Timoney, et al.
American Journal of Clinical Oncology|June 11, 2003
Gemcitabine-induced peripheral edema: report on 15 cases and review of the literatureChristopher G Azzoli, Vincent A Miller, Kenneth K Ng, et al.
Pharmacotherapy|May 29, 2008
Continued challenges with the use of erythropoiesis-stimulating agents in patients with cancer: perspectives and issues on policy-guided health careRebecca B Arbuckle, Niesha L Griffith, Lew M Iacovelli, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 23, 2008
NCCN Task Force Report: Oral chemotherapySaul N Weingart, Elizabeth Brown, Peter B Bach, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 7, 2007
Extended-dosage-interval regimens of erythropoietic agents in chemotherapy-induced anemiaRaymond J Muller, David Baribeault
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 22, 2013
National survey on the effect of oncology drug shortages on cancer careAli McBride, Lisa M Holle, Colleen Westendorf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 3, 2007
Bevacizumab 5 mg/kg can be infused safely over 10 minutesDiane L Reidy, Ki Y Chung, John P Timoney, et al.
American Journal of Clinical Oncology|June 11, 2003
Gemcitabine-induced peripheral edema: report on 15 cases and review of the literatureChristopher G Azzoli, Vincent A Miller, Kenneth K Ng, et al.
Pharmacotherapy|May 29, 2008
Continued challenges with the use of erythropoiesis-stimulating agents in patients with cancer: perspectives and issues on policy-guided health careRebecca B Arbuckle, Niesha L Griffith, Lew M Iacovelli, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 23, 2008
NCCN Task Force Report: Oral chemotherapySaul N Weingart, Elizabeth Brown, Peter B Bach, et al.
Pageof 1